Sarcomacrf Home Page
Welcome to Sarcomacrf, here you will find the list of all our subdomains
| Study URL | Description |
|---|---|
| URL | Project Description |
| immuno2.sarcomacrf.com | Phase II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas. |
| geis-67.sarcomacrf.com | Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcoma and osteosarcoma. |
| registro.sarcomacrf.com | Estudio observacional de la epidemiología e historia natural de tumores mesenquimales |
| geis-75.sarcomacrf.com | Phase II multicohort trial of trabectedin and low-dose radiation therapy in advanced/metastatic sarcomas. |
| immuno2-c7.sarcomacrf.com | Phase I-II trial of sunitinib and/or nivolumab plus chemotherapy in advanced soft tissue and bone sarcomas. |
| geis-74.sarcomacrf.com | Phase I/II randomized trial of LB-100 plus doxorubicin vs. doxorubicin alone in first line of advanced soft tissue sarcomas. |
| geis-37.sarcomacrf.com | Phase I-II prospective trial, multicenter, open label, exploring the combination of trabectedin plus radiotherapy in soft tissue sarcoma patients (TRASTS) |
| geis-37-CD.sarcomacrf.com | Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus Radiotherapy in Soft Tissue Sarcoma patients. |
| immuno2-c8.sarcomacrf.com | Phase I-II trial of sunitinib and/or nivolumab plus chemotherapy in advanced soft tissue and bone sarcomas. |
| geis-58.sarcomacrf.com | Phase I clinical trial of Olaratumab plus Trabectedin in advanced soft-tissue sarcoma patients (OLATRASTS) |
| geis-39.sarcomacrf.com | Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing's sarcoma. |
| central.sarcomacrf.com | Estudio sobre el impacto en el pronóstico y la calidad de vida del diagnóstico anatomopatológico centralizado de sarcomas de partes blandas en el estado español |
| geis-51.sarcomacrf.com | Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression |
| geis-41.sarcomacrf.com | A multicenter, phase Ib/II trial of Selinexor in combination with Imatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumors (GISTs)) |